Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development
- 29 March 2012
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 72 (3) , 363-372
Abstract
Objective: Drug exposure during critical periods of brain development may adversely affect nervous system function, posing a challenge for treating infants. This is of particular concern for treating neonatal seizures, as early life exposure to drugs such as phenobarbital is associated with adverse neurological outcomes in patients and induction of neuronal apoptosis in animal models. The functional significance of the preclinical neurotoxicity has been questioned due to the absence of evidence for functional impairment associated with drug‐induced developmental apoptosis.Methods: We used patch‐clamp recordings to examine functional synaptic maturation in striatal medium spiny neurons from neonatal rats exposed to antiepileptic drugs with proapoptotic action (phenobarbital, phenytoin, lamotrigine) and without proapoptotic action (levetiracetam). Phenobarbital‐exposed rats were also assessed for reversal learning at weaning.Results: Recordings from control animals revealed increased inhibitory and excitatory synaptic connectivity between postnatal day (P)10 and P18. This maturation was absent in rats exposed at P7 to a single dose of phenobarbital, phenytoin, or lamotrigine. Additionally, phenobarbital exposure impaired striatal‐mediated behavior on P25. Neuroprotective pretreatment with melatonin, which prevents drug‐induced neurodevelopmental apoptosis, prevented the drug‐induced disruption in maturation. Levetiracetam was found not to disrupt synaptic development.Interpretation: Our results provide the first evidence that exposure to antiepileptic drugs during a sensitive postnatal period impairs physiological maturation of synapses in neurons that survive the initial drug insult. These findings suggest a mechanism by which early life exposure to antiepileptic drugs can impact cognitive and behavioral outcomes, underscoring the need to identify therapies that control seizures without compromising synaptic maturation. ANN NEUROL 2012;72:363–372Keywords
This publication has 74 references indexed in Scilit:
- Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the ratNeuropharmacology, 2012
- Pattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brainEpilepsia, 2011
- Early postnatal exposure of rats to lamotrigine, but not phenytoin, reduces seizure threshold in adulthoodEpilepsia, 2011
- Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of ageBrain, 2011
- Therapeutic strategies to avoid long‐term adverse outcomes of neonatal antiepileptic drug exposureEpilepsia, 2010
- A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapyEpilepsy & Behavior, 2009
- Age- and gender-related differences in GABAA receptor-mediated postsynaptic currents in GABAergic neurons of the substantia nigra reticulata in the ratNeuroscience, 2009
- Spatial discrimination reversal learning in weanling rats is impaired by striatal administration of an NMDA-receptor antagonistLearning & Memory, 2009
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic DrugsNew England Journal of Medicine, 2009
- Cognitive abilities and behaviour of children exposed to antiepileptic drugs in uteroCurrent Opinion in Neurology, 2009